- US-listed companies
- INSMED Inc
- Income statement
INSMED IncINSM
Market cap
$40.1B
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 4 | - | 12 | - | - | - | - | 10 | 136 | 164 | 188 | 245 | 305 | 364 |
| Revenue growth (%) | - | - | - | - | - | - | - | - | ||||||
| Cost of revenue | - | - | - | - | - | - | - | 2 | 24 | 40 | 44 | 55 | 66 | 86 |
| Gross profit | - | - | - | - | - | - | - | - | 112 | - | - | - | - | - |
| Gross margin (%) | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| Research & development | 28 | 30 | 44 | 56 | 74 | 123 | 110 | 145 | 132 | 181 | 273 | 398 | 571 | 598 |
| Selling, general & administrative | - | - | - | - | - | - | - | - | - | - | - | - | - | 461 |
| Operating margin (%) | - | - | - | - | - | |||||||||
| Operating income | -62 | -42 | -55 | -87 | -117 | -173 | -189 | -307 | -235 | -265 | -375 | -457 | -710 | -878 |
| Operating expenses | 66 | 42 | 67 | 87 | 117 | 173 | 189 | 317 | 348 | 430 | 564 | 703 | 1,015 | 1,242 |
| Income before tax | -60 | -41 | -57 | -90 | -120 | -176 | -193 | -324 | -254 | -293 | -436 | -480 | -747 | -910 |
| Pretax margin (%) | -1,350.8 | - | -498.2 | - | - | - | - | -3,295.1 | -185.8 | -178 | -231.6 | -195.7 | -244.8 | -250.2 |
| Provision for income taxes | - | - | -1 | -10 | -2 | 0 | -0 | 0 | 1 | 1 | -2 | 1 | 3 | 4 |
| Effective tax rate (%) | - | - | ||||||||||||
| Net income | -60 | -41 | -56 | -79 | -118 | -176 | -193 | -324 | -254 | -294 | -435 | -482 | -750 | -914 |
| Net income margin (%) | - | - | - | - | - | |||||||||
| Earnings per share | -2.95 | - | - | - | - | - | - | - | - | - | -3.88 | -3.91 | -5.34 | -5.57 |
| Diluted EPS | -2.95 | - | - | - | - | - | - | - | - | - | -3.88 | -3.91 | -5.34 | -5.57 |
| EBITDA | - | - | - | - | - | - | - | |||||||
| EBITDA margin (%) | - | - | - | - | - | - | - | - | - | - | - | - |